BERGAMASCHI, R.; CAPOBIANCO , M.; RAVASIO, R. Budget impact analysis of natalizumab biosimilar on pharmaceutical expenditure for the treatment of relapsing-remitting multiple sclerosis in Italy. AboutOpen, [S. l.], v. 11, n. 1, p. 48–56, 2024. DOI: 10.33393/ao.2024.3078. Disponível em: https://journals.aboutscience.eu/index.php/aboutopen/article/view/3078. Acesso em: 3 jul. 2024.